TD Cowen began coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Get Rating) in a research report sent to investors on Thursday, Briefing.com reports. The firm issued an outperform rating on the stock. Separately, HC Wainwright decreased their target price on Cullinan Oncology from $50.00 to $49.00 in a research report on Friday, May 12th. […]
Cullinan Oncology (NASDAQ:CGEM – Get Rating) had its target price cut by HC Wainwright from $50.00 to $49.00 in a research report released on Friday morning, The Fly reports. Separately, Morgan Stanley cut their price target on Cullinan Oncology from $27.00 to $19.00 and set an overweight rating on the stock in a report on […]